Addictions, Drug & Alcohol Institute
Addictions, Drug & Alcohol Institute > ADAI Publications

ADAI Publications

1331 publications found

  1. Lyons VH, Floyd AS, Griffin E, Wang J, Hajat A, Carone M, Benkeser D, Whiteside LK, Haggerty KP, Rivara FP, Rowhani-Rahbar A. Helping individuals with firearm injuries: A cluster randomized trial. Journal of Trauma and Acute Care Surgery 2021;90(4):722-730. [doi: 10.1097/TA.0000000000003056] PMID: 33405475 PMCID: PMC7979484
  2. Becker SJ, Murphy CM, Hartzler B, Rash CJ, Janssen T, Roosa M, Madden L, Garner BR. Project MIMIC (Maximizing Implementation of Motivational Incentives in Clinics): A Cluster-randomized type 3 hybrid effectiveness-implementation trial. Addiction Science & Clinical Practice 2021;16:61. [doi: 10.1186/s13722-021-00268-0] PMID: 34635178 PMCID: PMC8505014
  3. Peavy KM, Banta-Green C. Group Counseling for People in Medication Treatment for Opioid Use Disorder. Seattle, WA: Addictions, Drug & Alcohol Institute, Department of Psychiatry & Behavioral Sciences, School of Medicine, University of Washington, June 2021
  4. Lillie KM, Jansen KJ, Dirks LG, Lyons AJ, Alcover KC, Avey JP, Hirchak K, Herron J, Buchwald D, Donovan DM, McDonnell MG, Shaw JL. Assessing the predictive validity of the Stages of Change Readiness and Treatment Eagerness Scale (SOCRATES) in Alaska Native and American Indian people. Journal of Addiction Medicine 2020;14(5):e241-e246. [doi: 10.1097/ADM.0000000000000661] PMID: 32371661 PMCID: PMC7541407
  5. McMahan VM, Kingston S, Newman A, Stekler JD, Glick SN, Banta-Green CJ. Interest in reducing methamphetamine and opioid use among syringe services program participants in Washington State. Drug and Alcohol Dependence 2020;216:108243. [doi: 10.1016/j.drugalcdep.2020.108243] PMID: 32911134 PMCID: PMC9632690
  6. Firth CL, Carlini BH, Dilley J, Wakefield J, Hajat A. What about equity? Neighborhood deprivation and cannabis retailers in Portland, Oregon. Cannabis 2020;3(2):157-172. [doi: 10.26828/cannabis.2020.02.003]
  7. Hood JE, Banta-Green CJ, Duchin JS, Breuner J, Dell W, Finegood B, Glick SN, Hamblin M, Holcomb S, Mosse D, Oliphant-Wells T, Shim MM. Engaging an unstably housed population with low-barrier buprenorphine treatment at a syringe services program: Lessons learned from Seattle, Washington. Substance Abuse 2020;41(3):356-364. [doi: 10.1080/08897077.2019.1635557] PMID: 31403907
  8. Carpenter KM, Torres AJ, Salmon EE, Carlini BH, Vickerman KA, Schauer GL, Bush T. Marijuana use and adherence to smoking cessation treatment among callers to tobacco quitlines. Preventing Chronic Disease 2020;17:200110. [doi: 10.5888/pcd17.200110] PMID: 32915131 PMCID: PMC7553215
  9. Firth CL, LaBrie JW, D'Amico EJ, Klein DJ, Griffin BA, Pedersen ER. Changes in cigarette, e-cigarette and cannabis use among college students studying abroad. Substance Use & Misuse 2020;55(10):1683-1691. [doi: 10.1080/10826084.2020.1756853] PMID: 32364038 PMCID: PMC7485612
  10. McMahan VM, Frank N, Buckler S, Violette LR, Baeten JM, Banta-Green CJ, Barnabas RV, Simoni J, Stekler JD. Protocol development for HMU! (HIV Prevention for Methamphetamine Users), a study of peer navigation and text messaging to promote pre-exposure prophylaxis adherence and persistence among people who use methamphetamine: Qualitative focus group and interview study. JMIR Formative Research 2020;4(9):e18118. [doi: 10.2196/18118] PMID: 32924952 PMCID: PMC7522731
  11. Pedersen ER, Firth CL, Parker J, Shih RA, Davenport S, Rodriguez A, Dunbar MS, Kraus L, Tucker JS, D'Amico EJ. Locating medical and recreational cannabis outlets for research purposes: online methods and observational study. Journal of Medical Internet Research 2020;22(2):e16853. [doi: 10.2196/16853] PMID: 32130141 PMCID: PMC7066509
  12. Haggerty KP, Carlini BH. Commentary: Understanding the intergenerational transmission of substance use and problem behavior: Implications for future research and preventive interventions. Psychology of Addictive Behaviors 2020;34(8):894-897. [doi: 10.1037/adb0000624]
  13. Hartzler B, Vandersloot D. The role of an intermediary purveyor organization in identifying and responding to workforce priorities to combat the opioid epidemic [conference abstract]. Addiction Science & Clinical Practice 2020;15(suppl2):A65. [doi: 10.1186/s13722-020-00208-4]
  14. Larimer ME, Parker M, Lostutter T, Rhew I, Eakins D, Lynch A, Walter T, Egashira L, Kipp BJ, Duran B. Perceived descriptive norms for alcohol use among tribal college students: Relation to self-reported alcohol use, consequences, and risk for alcohol use disorder. Addictive Behaviors 2020;102:106158. [doi: 10.1016/j.addbeh.2019.106158] PMID: 31830672
  15. Hildebrandt UC, Graham JC, Grant TM. Predictors and moderators of improved social-emotional functioning in mothers with substance use disorders and their young children enrolled in a relationship-based case management program. Infant Mental Health Journal 2020;41(5):677-696. [doi: 10.1002/imhj.21872] PMID: 32578238
  16. Firth CL, Hajat A, Dilley J, Braun M, Maher JE. Implications of cannabis legalization on juvenile justice outcomes and racial disparities. American Journal of Preventive Medicine 2020;58(4):562-569. [doi: 10.1016/j.amepre.2019.11.019] PMID: 32033855 PMCID: PMC7266456
  17. Hendershot CS, Dermody SS, Wardell JD, Zaso MJ, Kennedy JL, Stoner SA. OPRM1 moderates daily associations of naltrexone adherence with alcohol consumption: preliminary evidence from a mobile health trial. Alcohol: Clinical & Experimental Research 2020;44(4):983-991. [doi: 10.1111/acer.14300] PMID: 32020635 PMCID: PMC8758337
  18. Harwick R, Carlini BH, Garrett SB. A taxonomy of consumers’ perspectives on the function of cannabis in their lives: A qualitative study in WA State, USA. Journal of Psychoactive Drugs 2020;52(5):393-400. [doi: 10.1080/02791072.2020.1763522] PMID: 32501752
  19. Becker SJ, Garner B, Hartzler B, Rash C, Murphy C, Moul S, Yap K, Yermash J, Ball E, Roosa M, Madden L. Maximizing implementation of contingency management in opioid treatment programs: Process data from the first cohort of a type 3 hybrid trial. [conference abstract]. Addiction Science & Clinical Practice 2020;15(suppl2):A60. [doi: 10.1186/s13722-020-00208-4]
  20. Hallgren K, Witwer E, West I, Baldwin LM, Donovan DM, Stuvek BK, Keppel G, Mollis B, Stephens K. Prevalence of documented alcohol and opioid use disorder diagnoses and treatments in a regional primary care practice-based research network. Journal of Substance Abuse Treatment 2020;110:18-27. [doi: 10.1016/j.jsat.2019.11.008] PMID: 31952624 PMCID: PMC7255441